Intermediates

3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine

  • CAS No.151266-23-8
  • GradeIndustrial / Pharmaceutical
  • Availability● In Stock

Premium grade 3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine designed for kinase inhibitor synthesis. Available in bulk with strict quality control and comprehensive documentation.

Request Bulk Pricing

Product Technical Details

Product Overview

3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine is a highly specialized heterocyclic compound serving as a vital building block in modern pharmaceutical synthesis. This iodinated pyrazolo-pyrimidine derivative is engineered to meet the rigorous demands of medicinal chemistry, particularly in the development of targeted kinase inhibitors. Our manufacturing process ensures exceptional batch-to-batch consistency, making it an ideal candidate for complex organic synthesis pathways where reliability and purity are paramount.

Chemical Properties and Structure

The molecular architecture of this compound features a fused pyrazolo-pyrimidine core substituted with an iodine atom at the third position and an amine group at the fourth position. This specific substitution pattern facilitates versatile cross-coupling reactions, such as Suzuki or Heck couplings, which are essential for constructing larger biologically active molecules. The presence of the iodine moiety significantly enhances reactivity, allowing chemists to efficiently introduce diverse functional groups during the drug discovery process.

Technical Specifications

ParameterSpecification
Chemical Name3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine
CAS Number151266-23-8
Molecular FormulaC5H4IN5
Molecular Weight261.02 g/mol
Purity (HPLC)≥98.0%
AppearanceOff-white to yellow to light brown powder
Melting Point24ºC
Storage ConditionsCool, ventilated place

Industrial Applications

This intermediate is primarily utilized in the synthesis of Ibrutinib, a groundbreaking Bruton's tyrosine kinase (BTK) inhibitor used in treating certain B-cell malignancies. The high purity levels provided by our facility ensure that downstream reactions proceed with minimal side products, optimizing overall yield and reducing purification costs. Beyond Ibrutinib, this scaffold is valuable for researching next-generation therapeutics targeting various signaling pathways involved in oncology and immunology.

Quality Assurance and Packaging

We adhere to strict quality management systems to guarantee the integrity of every shipment. Each batch undergoes comprehensive analysis using high-performance liquid chromatography (HPLC) and other advanced spectroscopic methods. A Certificate of Analysis (COA) is provided with every order, detailing all critical quality attributes. Our standard packaging consists of 25 kg drums, though we offer flexible customization to suit specific logistical requirements. Proper storage in a cool and ventilated environment is recommended to maintain stability over extended periods.

Why Choose Our Intermediates

  • Consistent high purity suitable for GMP manufacturing
  • Scalable production capacity for bulk requirements
  • Comprehensive technical support and documentation
  • Competitive pricing for global pharmaceutical partners
  • Secure logistics and timely delivery worldwide